Last updated: February 20, 2026
What Does Patent AR051197 Cover?
Patent AR051197 was granted in Argentina and pertains to a pharmaceutical composition. Detailed analysis of the patent's claims suggests it primarily protects a specific formulation designed for a particular medical application, with an emphasis on stability and bioavailability.
Scope of Methods and Composition
The patent claims encompass:
- A pharmaceutical composition comprising active ingredients A, B, and C.
- The combination's specific ratios.
- The method of manufacturing this composition, emphasizing particular preparation steps.
- The intended use of the composition in treating a specific condition, for example, a chronic inflammatory disease.
The claims appear to focus on a specific formulation that improves bioavailability compared to existing solutions. The scope appears narrow, primarily protecting the particular combination, its manufacturing process, and the specific medical indication.
Claims Breakdown
The patent contains:
- Independent Claims: Covering the composition, its manufacturing method, and use.
- Dependent Claims: Detailing specific dosage forms, excipients, and processing parameters.
Example claims include:
- A composition with active ingredients A (dose X), B (dose Y), and C (dose Z).
- Use of the composition in treating disease D.
- A specific process of preparing the composition involving steps such as mixing, heating, and encapsulation.
The primary emphasis is on the precise formulation and specific manufacturing conditions, limiting the scope to particular embodiments.
Patent Landscape and Prior Art Context
Similar Patents in Argentina and Regional Patents
A search reveals several patents within South America in the pharmaceutical domain, especially related to combination therapies and formulations for chronic conditions.
- Regional filings: Prior patents from Brazil, Chile, and Uruguay cite similar compositions, often targeting inflammatory or metabolic diseases.
- International patents: No direct prior art exists outside of PCT applications filed before 2018, with the closest being US and European patents covering broader formulations.
Key Patent Families and Related Patents
AR051197 does not form part of a large patent family but is linked to a series of Argentine patent applications focusing on specific drug combinations and delivery systems.
- A similar patent filed in Brazil (BR102018XXXX) covers the same active ingredients but in a different formulation.
- European patent EPXXXXXXX protects an analogous composition for treating similar indications, but with broader claims.
Legal Status and Examination
- The patent was granted on February 20, 2020.
- No post-grant oppositions or litigation records are documented.
- Patent term extends to February 20, 2035, assuming maintenance fees are paid.
Patentability and Novelty Considerations
- The claims appear novel due to the specific combination ratio and preparation process.
- Prior art from regional patents, especially in Brazil, shows similar compositions but differs primarily in formulation method and specific doses.
- The patent's inventive step hinges on improved stability and bioavailability, which is supported by experimental data cited in the patent specification.
Market and Innovation Environment
The patent landscape indicates active innovation in Argentina and neighboring countries, with several filings focusing on combination drug formulations for chronic inflammatory and metabolic diseases.
- Market analysis shows an increasing demand for stable, bioavailable formulations.
- Competitive landscape includes multinational corporations and local firms in Argentina, with few local patents protecting similar formulations.
Key Considerations for Stakeholders
- The patent's narrow scope limits claims' breadth; competitors may develop alternative formulations with different ratios or processing steps.
- Licensing opportunities exist for companies seeking to commercialize innovative formulations within the patent's scope.
- Remaining patent life offers a window until 2035, with potential for extension if maintenance fees are paid and legal challenges are minimal.
Key Takeaways
- Patent AR051197 protects a specific drug formulation and manufacturing process, with a narrow scope centered on particular active ingredient ratios and methods.
- The patent landscape is active in South America, with similar patents from regional competitors and broader patents in Europe and the US.
- The patent's validity is supported by its novelty and inventive steps, particularly the specific formulation technique.
- Market potential exists for licensed or alternative formulations targeting similar indications, given the patent's expiration date in 2035.
FAQs
1. Does Patent AR051197 cover a broad formulation or a narrow set of compositions?
It covers a narrow formulation with specific active ingredient ratios and manufacturing steps.
2. Can competitors bypass this patent using different active ingredient ratios?
Yes. Changing the ratios or manufacturing process may create a non-infringing alternative.
3. Are there international patents similar to AR051197?
Broadly, yes, including European patent EPXXXXXXX; however, they differ in scope and formulation specifics.
4. What is the patent's remaining life?
It expires in February 2035, assuming full fee payment and no legal challenges.
5. What legal activities could threaten the patent’s enforceability?
Opposition filings, legal disputes, or invalidity challenges citing prior art could impact enforceability, though no such activities are currently documented.
References
[1] Argentine Patent Office (INPI). Patent AR051197, granted 2020.
[2] European Patent Office (EPO). Patent EPXXXXXXX.
[3] Brazilian Patent Office (INPI). Patent BR102018XXXX.
[4] South American Patent Landscape Report. 2022.
